N/N Anemias Flashcards
Aplastic anemia
- Common cause
Idiopathic (unknown cause)
Aplastic anemia
- 4 secondary causes
- Chemicals (benzene, arsenic, insecticides, weed killers)
- Drugs (chloramphenical)
- Radiation (long term, low dose)
- Infections, esp. chronic ( Hepatitis C, EBV, CMV, HIV)
Aplastic anemia
- Name of most comon congenital disorder associated w/ it
Fanconi’s anemia
Aplastic anemia
- BM cellularity
Hypocellular
Aplastic anemia
- CBC
- WBC < 1500/cumm
- ↓ RBC
- Hb < 7 g/dL
- ↓ Hct
- ↓ PLT
Aplastic anemia
- Characteristic RBC morphology
None, just few present
Aplastic anemia
- Retic count
Decreased to absent
Aplastic anemia
- Treatment
- Take away offending agent, if applicable
- “support” therapy as needed (antibiotics, blood products esp. plts, use of growth factors)
- immunosuppressive therapy to stimulate BM
- Only cure is BM transplant
Type of poik found in most every hemoglobinopathy
Sickle cells
Amino acid substitution found in sickle cell anemia
Glutamic acid replaced by valine
3 factors contributing to sickling process
- Hypoxia
- Acidosis
- Dehydration
Sickle cell anemia
- Cause of “painful crises”
Tissue damage from hypoxia
Sickle cell anemia
- Cause of “acute chest syndrome”
Infarction of organs
Sickle cell anemia
- Cause of high risk of infections
Splenomegaly to autosplenectomy
Sickle cell anemia
- Inheritance
Abnormal gene from both parents
Sickle cell anemia
- Hemoglobin nomenclature
SS
Sickle cell anemia
- Solubility (Sickledex) results
Hemoglobin S is insoluble → precipitates in solution = turbid (+)
Sickle cell anemia
- Hemoglobin electrophoresis results
S > F (no A)
Sickle cell anemia
- RBC morphology
- Poik → “targets plus” sickles, schistos, spheres
- Polychromasia (increased retic count)
- RBC inclusions → H-J bodies, Pappenhemier
- nRBCs
Sickle cell anemia
- Treatment
- Adequate hydration
- Pain relief from crises (morphine)
- Antibiotics
- Blood transfusions
- Hydroxyurea to increase hemoglobin F…relieve sickling
Sickle cell trait
- Inheritance
Abnormal gene from one parent
Sickle cell trait
- Hemoglobin nomenclature
AS
Sickle cell trait
- Solubility (Sickledex) results
Hemoglobin A is soluble = solution remains clear (-)
Sickle cell trait
- Hemoglobin electrophoresis results
A > S
Sickle cell trait
- RBC morphology
- Slight targets
- No sickles (treatment may occur under severe hypoxic states)
Sickle cell trait
- Treatment
No treatment necessary
Sickledex solubility (screening) test
- Principle
Blood added to buffered solution of reducing agent
Sickledex solubility (screening) test
- Reducing agent
Sodium dithionite or sodium metabisulfite
Sickledex solubility (screening) test
- Causes for false positive results
- Proteinemia
- > 18 g/dL hemoglobin
- Other sickling hemoglobins
Sickledex solubility (screening) test
- Causes for false negative results
- Testing a newborn
- < 7 g/dL hemoglobin
- Multiple transfusions
Amino acid substitution found in hemoglobin C disease
Glutamic acid substituted w/ lysine
Hemoglobin C disease
- Clinical presentation
Mildly hemolytic anemia
Hemoglobin C disease
- Hemoglobin nomenclature
CC
Hemoglobin C disease
- Hemoglobin electrophoresis results
100% C (no A)
Hemoglobin C disease
- RBC morphology
- Poik → “targets plus” C crystals
- Polychromasia (increased retic count)
Hemoglobin C trait
- Clinical presentation
Asymptomatic
Hemoglobin C trait
- Hemoglobin nomenclature
AC
Hemoglobin C trait
- Hemoglobin electrophoresis results
A > C
Hemoglobin C trait
- RBC morphology
Targets only
Hemoglobin SC disease
- Inheritance
- Lysine substitution (C) from one parent
- Valine substitution (S) from the other
Hemoglobin SC disease
- Clinical presentation
Less severe than sickle cell disease (SS), but still mild-moderately (severe) hemolytic anemia w/ painful crises
Hemoglobin SC disease
- Hemoglobin electrophoresis results
S = C
Hemoglobin SC disease
- RBC morphology
- Poik → “targets plus” sickles, C crystals, and SC crystals
- Polychromasia (increased retic count)
- RBC inclusions (H-J bodies, Pappenheimer)
- nRBCs
Sickle cell ß thal
- Inheritance
- Valine substitution from one parent
- ß0 or ß+ from the other
Sickle cell ß thal
- Clinical presentation (sickle ß0 thal vs. sickle ß+ thal)
- ß0 → severe hemolytic anemia
- ß+ → mild to moderate hemolytic anemia
Sickle cell ß thal
- Hemoglobin electrophoresis results (sickle ß0 thal vs. sickle ß+ thal)
- ß0 → S > F (↑) > A2 (↑) w/ no A
- ß+ → S > A > F (↑) > A2 (↑)
Sickle cell ß thal
- RBC morphology (sickle ß0 thal vs. sickle ß+ thal)
- ß0 and ß+ → “targets plus” sickles (sickles may be absent w/ mild ß+), schistos, spherocytes, nRBCs
2 ways that hemoglobin D may be differentiated from hemoglobin S since they both migrate to the same point on cellulose acetate electrophoresis
- Solubility testing (hemoglobin D will be negative)
- Citrate (acid) electrophoresis
World’s third most common abnormal hemoglobin (behind Hb S and Hb C) and indicate the geographic ara in which it commonly occurs
- Hemoglobin E
- Common in SE Asia
Physiological mechanism for predominant type of poik found in hereditary spherocytosis
↓ spectrin causes ↑ permeability of sodium into cell
Physiological mechanism for predominant type of poik found in hereditary elliptocytosis
↓ cholesterol in cell membrane causes Hb to polarize to opposite ends
Physiological mechanism for predominant type of poik found in hereditary stomatocytosis
Defect in NaK-ATPase pump → ↓ Na+ in and ↑ K+ out → abnormal slit-like pallor
Hereditary spherocytosis
- Clinical presentation
Anemia, jaundice, splenomegaly
Hereditary spherocytosis
- RBC indices
- ~12 g/dL hemoglobin
- MCHC = 36-38%
Hereditary spherocytosis
- RBC morphology
- Variable # in spheres
- Polychromasia (increased retic count)
Osmotic fragility test
- Principle
Blood is added to series of hypotonic salt solutions, beginning and completion of hemolysis are noted
Osmotic fragility
- Conditions that show “increased osmotic fragility”
Hereditary spherocytosis
Osmotic fragility test
- Conditions that show “decreased osmotic fragility”
- Thalassemia
- Sickle cell anemia
- Any hypochromic anemia
Osmotic fragility test
- Conditions that show “decreased resistance to hemolysis”
Hereditary spherocytosis
Osmotic fragility test
- Conditions that show “increased resistance to hemolysis”
- Thalassemia
- Sickle cell anemia
- Any hypochromic anemia
Osmotic fragility test
- NaCl concentration when hemolysis should begin (in a normal person)
0.45-0.5% NaCl
Osmotic fragility test
- NaCl concentration when hemolysis should be completed (in a normal person)
0.3-0.35% NaCl
Type of poik that demonstrates greatest resistance to hemolysis
Target cells, hypochromic sickles
Expected results that occur w/ any hemolytic anemia
- Plasma haptoglobin
Decreased
Expected results that occur w/ any hemolytic anemia
- Retic count
Increased
Expected results that occur w/ any hemolytic anemia
- Serum bilirubin
Increased
G-6-PD deficiency
- Result of deficient enzyme
- Type of poik or inclusion bodies present
- Triggering factor
- Glutathione is not reduced
- Heinz bodies, bite cells
- Administration of new drug, infection, ingestion of fava beans, ingestion of moth balls
PK deficiency
- Result of deficient enzyme
- Type of poik or inclusion bodies present
- Triggering factor
- Decreased capacity to generate ATP
- Burr cells
- Triggering factors?
Methemoglobin reductase deficiency
- Result of deficient enzyme
- Type of poik or inclusion bodies present
- Triggering factor
- Increased levels of methemoglobin
- Poik?
- Triggering factors?
Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Etiology
- Causes cells, esp. RBCs, to be more sensitive than normal to lytic action of complement (in an acid environment)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Clinical presentation
- “sleep-induced hemolytic anemia” → bloody first morning urine, clears throughout day
Paroxysmal Nocturnal Hemoglobinuria (PNH)
- CBC
Pancytopenia
Paroxysmal Nocturnal Hemoglobinuria (PNH)
- RBC morphology
None
Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Ham’s test results
Positive
Principle of Ham’s test
Due to intrinsic membrane defect, PNH red cells are more sensitive to lysis by complement. A pH of 6.7-7.0 and 37°C provide optimum conditions for complement activation via alternate pathway and subsequent lysis fo PNH red cells
3 conditions that may cause an alloimmune hemolytic anemia to develop
- Transfusions
- Pregnancy (HDFN)
- Organ transplantation
Abnormality in immune system whereby the ability for self-recognition of an individual’s own red cell Ags is lost
Autoimmune hemolytic anemia
Abs produced by one individual react w/ Ags of another individual
Alloimmune hemolytic anemia
Cold agglutinin
- Alloimmune vs. autoimmune
Cold autoimmune
Cold agglutinin
- CBC results
↓ RBC, Hb, Hct
↑ MCV and RDW
Cold agglutinin
- RBC morphology
Clumping of RBCs due to IgM Ab
Ab associated with paroxysmal cold hemoglobinuria
IgM?
2 disorders commonly associated w/ microangiopathic hemolytic anemia (MAHA)
- Hemolytic uremic syndrome (HUS)
- Thrombotic thrombocytopenic purpura (TTP)
- Disseminated intravascular coagulation (DIC)
Predominant type of poik found in MAHA
Schistocytes